In April 2021 the FDA released a new question & answer guidance document for the industry, specifically addressing Generics and their challenges during the COVID-19 pandemic. As the guidance is coming into effect immediately without prior public comments, it is worth having a closer look. The FDA has issued this guidance to provide general recommendations …
Author Archives: Olaf Schoepke
EMA’s new veterinary product information template
To be able to support the new veterinary regulations coming into effect in January 2022, the EMA updated the product information template that can be accessed here . The new template includes a new section on restrictions on the use of antimicrobials and antiparasitic veterinary products in an attempt to reduce resistance. The other thing …
Continue reading “EMA’s new veterinary product information template”
EMA electronic Product Information (ePI) Consultation
Expert and public comments sought on ePI, open until 31/July/2021. The EMA has opened a public consultation on the draft EU common standard for electronic product information or ePI. The consultation period is open until end of July 2021 so there is little time left to give feedback. Comments should be provided via an online …
Continue reading “EMA electronic Product Information (ePI) Consultation”
EU pilot project ‘Market Launch of Centrally Authorised Medicinal Products’
Action required: Pilot started 25/March/2021. In March 2021 the European Commission, together with the EMA and Member States, committed to initiate a pilot to better understand the root causes of deferred market launches for centrally authorised products. The initiative has been launched with the engagement of future Marketing Authorisation Holders (MAHs). The pilot’s overall objective …
Continue reading “EU pilot project ‘Market Launch of Centrally Authorised Medicinal Products’”
Can our four-legged friends help us get out of the COVID-19 pandemic?
Dogs are well known for their abilities to sniff out drugs even when hidden in the most concealed containers. K-9s assist humans worldwide by supporting the visually disadvantaged, hearing impaired and diabetic patients and they are well known to many of us undertaking security checks on airports. In more recent years though dogs are also …
Continue reading “Can our four-legged friends help us get out of the COVID-19 pandemic?”
SPC harmonisation: Call for Contribution to the Public Consultation of the Best Practice Guides of the CMDv
Action required: Consultation period for ‘SPC harmonisation’ ends 29/June/2021. The CMDv (Co-Ordination Group for Mutual Recognition and Decentralised Procedure – Veterinary) is seeking feedback on its Best Practice Guides (NPGs) related to the New Veterinary Regulation (NVR), coming into effect on 28/January/2022. The Best Practice Guides have either been newly created or are updated accordingly. …
EMA introduces additional measures to streamline assessments
Published by the EMA 11/May/2021. In the process of streamlining assessment for medicinal products during the COVID-19 pandemic, the EMA is implementing additional temporary measures in the European medicines regulatory network . This should allow assessors to concentrate on the ever-increasing volume of COVID-19-related applications, whether vaccines or treatments. The focus will be on vaccines …
Continue reading “EMA introduces additional measures to streamline assessments”
New EMA veterinary product information template
Action required: The EMA invites comments for the new product information template by 14/May/2021. The EMA just released a new product information template for public consultation. Besides smaller adjustments, the template mainly addresses changes required in line with the New Veterinary Regulations (NVR) that is coming into effect January 2022. Although no firm date for …
Continue reading “New EMA veterinary product information template”
EMA’s PRIME draft toolbox: Consultation ends July 2021
Action required: Consultation for the EMA PRIority MEdicine (PRIME) draft toolbox guidance closes 31st July 2021. What is PRIME about? The European Medicines Agency (EMA) launched the PRIority MEdicines (PRIME) scheme in March 2016. The scheme was launched to provide early and enhanced scientific and regulatory support for medicines that target an unmet medical need. …
Continue reading “EMA’s PRIME draft toolbox: Consultation ends July 2021”
FDA Adverse Event Reporting System (FAERS)
FDA launches FAERS public dashboard for COVID-19 emergency use authorization products. Covid-19 is currently in the news worldwide and that on a daily basis. With vaccinations now becoming more widely available, not only healthcare professionals are interested in post vaccination information. The public too is getting hungrier not only for information on vaccination success, but …
Continue reading “FDA Adverse Event Reporting System (FAERS)”
Pharma Whisper 